You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Johnson and Johnson
Mallinckrodt
Dow
Harvard Business School

Last Updated: February 22, 2020

DrugPatentWatch Database Preview

Pegfilgrastim - Biologic Drug Details


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for pegfilgrastim

Identify potential brand extensions & biosimilar entrants

SponsorPhase
University of WashingtonPhase 1
BayerPhase 1
Kyowa Hakko Kirin Co., LtdPhase 2

See all pegfilgrastim clinical trials

Recent Litigation for pegfilgrastim

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD.2019-07-12
Amgen Inc. v. Accord BioPharma2018-08-07
CELGENE CORPORATION v. SYNTHON PHARMECEUTICALS, INC.2018-06-19

See all pegfilgrastim litigation

Company Disclosures: US Patents for pegfilgrastim

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31   Start Trial Amgen Inc. (Thousand Oaks, CA) 2013-12-03 RX Orphan company
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31   Start Trial Amgen Inc. (Thousand Oaks, CA) 2013-12-10 RX Orphan company
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31   Start Trial Amgen Inc. (Thousand Oaks, CA) 2039-02-26 RX Orphan company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for pegfilgrastim

These patents were identified by searching patent claims

Supplementary Protection Certificates for pegfilgrastim

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
006 Luxembourg   Start Trial
C0048 France   Start Trial PRODUCT NAME: PEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/02/228/001 20020822
299044 Germany   Start Trial PRODUCT NAME: PEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/02/227/001 20020822
5/2003 Austria   Start Trial PRODUCT NAME: PEGFILGRASTIM
00106 Netherlands   Start Trial PRODUCT NAME: PEGFILGRASTIM; NAT. REGISTRATION NO/DATE: EU/1/02/228/001 20020822; FIRST REGISTRATION: EU/1/02/228/001 20020822
2003 00002 Denmark   Start Trial
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.